telehealth glp-1 crackdown news today FEDS CRACK DOWN ON COMPANIES SELLING GLP-1s: The U.S. Food and Drug Administration is cracking down on telehealth companies for making “false and misleading” claims about compounded versions of popular weight GLP-1 Telehealth Provider Comparison: Which

Access to the WeightCare One app to track progress and chat with nutritionists and trainers

Despite having greater access to preventive care, Medicare Advantage beneficiaries had poorer intermediate health outcomes and were less likely to receive newer diabetes drug therapies compared with those with fee-for-service Medicare.“Medicare Advantage plans often leverage incentive structures to maintain care quality while limiting excessive health care utilization

Guidelines currently recommend organ-specific management of obesity-related complications

Semaglutide pens require careful refrigeration to maintain medication strength

Zachariah Reitano, co-founder and CEO of Ro, the direct-to-patient healthcare company, discusses the ripple effects of GLP1 medications such as Ozempic and Wegovy.

The once-daily pill offers new oral cardiovascular risk-reduction option for plan members with diabetes